K252851 is an FDA 510(k) clearance for the deepLive (OSP12 + DMS), a System, Imaging, Optical Coherence Tomography (oct) (Class II — Special Controls, product code NQQ), submitted by Damae Medical (Paris, FR). The FDA issued a Cleared decision on October 7, 2025, 29 days after receiving the submission on September 8, 2025. This device falls under the General & Plastic Surgery review panel. Regulated under 21 CFR 892.1560.
| 510(k) Number | K252851 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 08, 2025 |
| Decision Date | October 07, 2025 |
| Days to Decision | 29 days |
| Submission Type | Special |
| Review Panel | General & Plastic Surgery (SU) |
| Summary | Summary PDF |
| Product Code | NQQ — System, Imaging, Optical Coherence Tomography (oct) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 892.1560 |
| Definition | This Device Uses Back-reflected Light To Create Two-dimensional Images Versus Back-reflected Sound Waves As Are Used In Ultrasound Imaging. |